Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
Aim: To investigate the relationship of sodium/iodide symporter (NIS) expression with molecular phenotype of highly and low malignant cell lines of human breast cancer (BC) with different sensitivity to doxorubicin (Dox). Materials and Methods: The cell lines used in the analysis included T47D, MCF-...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2016 |
| Main Authors: | Lukianova, N.Yu., Andriiv, A.V., Chekhun, V.F. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2016
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/137741 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin / N.Yu. Lukianova, A.V. Andriiv, V.F. Chekhun // Experimental Oncology. — 2016 — Т. 38, № 3. — С. 169-171. — Бібліогр.: 18 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
The value of iodide symporter for prognosis of breast cancer of different molecular subtypes
by: Yu. Lukianova, et al.
Published: (2017)
by: Yu. Lukianova, et al.
Published: (2017)
Fractal dimension of the breast cancer cells resistant and sensitive to doxorubicin activity
by: Medviediev, O., et al.
Published: (2016)
by: Medviediev, O., et al.
Published: (2016)
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)
by: Todor, I.N., et al.
Published: (2012)
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016)
by: Yalovenko, T.M., et al.
Published: (2016)
Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line
by: Rusetskaya, N.V., et al.
Published: (2011)
by: Rusetskaya, N.V., et al.
Published: (2011)
Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)
by: Chekhun, V.F., et al.
Published: (2016)
Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: S. V. Chekhun, et al.
Published: (2014)
by: S. V. Chekhun, et al.
Published: (2014)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: Chekhun, S.V., et al.
Published: (2014)
by: Chekhun, S.V., et al.
Published: (2014)
Features of hepcidin expression in patients with breast cancer
by: Yu. Lukianova, et al.
Published: (2015)
by: Yu. Lukianova, et al.
Published: (2015)
Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics
by: V. F. Chekhun, et al.
Published: (2016)
by: V. F. Chekhun, et al.
Published: (2016)
Effect of anticancer drugs on breast cancer cells sensitive and resistant to doxorubicin: expression of mRNAs of TGF-β and its receptors
by: Chorna, I.V., et al.
Published: (2014)
by: Chorna, I.V., et al.
Published: (2014)
Effect of anticancer drugs on breast cancer cells sensitive and resistant to doxorubicin: expression of mRNAs of TGF-β and its receptors
by: I. V. Chorna, et al.
Published: (2014)
by: I. V. Chorna, et al.
Published: (2014)
Dihydropyrimidine dehydrogenase activity correlates with fluorouracil sensitivity in breast cancer
by: Yu, Z., et al.
Published: (2007)
by: Yu, Z., et al.
Published: (2007)
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: Chekhun, S., et al.
Published: (2013)
by: Chekhun, S., et al.
Published: (2013)
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: S. Chekhun, et al.
Published: (2013)
by: S. Chekhun, et al.
Published: (2013)
Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
by: Naleskina, L.A., et al.
Published: (2016)
by: Naleskina, L.A., et al.
Published: (2016)
Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
by: Lukianova, N.Yu., et al.
Published: (2023)
by: Lukianova, N.Yu., et al.
Published: (2023)
Influence of ferromagnetic nanocomposite (Ferroplat) on human breast cancer cells of different malignancy degrees: pro/antioxidant balance and energy metabolism
by: Chekhun, V.F., et al.
Published: (2018)
by: Chekhun, V.F., et al.
Published: (2018)
Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018)
by: S. M. Hrybach, et al.
Published: (2018)
Association of circulating miR-21, -205, and -182 with response of luminal breast cancers to neoadjuvant FAC and AC treatment
by: Chekhun, V.F., et al.
Published: (2023)
by: Chekhun, V.F., et al.
Published: (2023)
Chemocine receptor CXCR4 expression and microvessels density in malignant tumors of the breast of patients with sings of metabolic syndrome
by: N. P. Yurchenko, et al.
Published: (2020)
by: N. P. Yurchenko, et al.
Published: (2020)
EpCAM expression in breast tumor cells and their relation to clinical and pathological parameters and molecular subtype of cancer
by: L. M. Kovalevska, et al.
Published: (2019)
by: L. M. Kovalevska, et al.
Published: (2019)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: O. V. Shepil, et al.
Published: (2014)
by: O. V. Shepil, et al.
Published: (2014)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: Shepil, O.V., et al.
Published: (2014)
by: Shepil, O.V., et al.
Published: (2014)
The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
by: V. F. Chekhun, et al.
Published: (2017)
by: V. F. Chekhun, et al.
Published: (2017)
Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
by: Bereznaya, N.M., et al.
Published: (2008)
by: Bereznaya, N.M., et al.
Published: (2008)
Molecular-genetic bases of clinical heterogeneity of breast cancer (literature review)
by: L. A. Nalieskina, et al.
Published: (2017)
by: L. A. Nalieskina, et al.
Published: (2017)
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
by: Todor, I.N., et al.
Published: (2015)
by: Todor, I.N., et al.
Published: (2015)
Heterogeneity of premetastatic niches gene expression in breast cancer cells
by: L. A. Tashireva, et al.
Published: (2015)
by: L. A. Tashireva, et al.
Published: (2015)
Adaptor protein Ruk/CIN85 modulates resistance to doxorubicin of murine 4T1 breast cancer cells
by: I. R. Horak, et al.
Published: (2018)
by: I. R. Horak, et al.
Published: (2018)
Expression analisis of the ITSN2 and TKS5 mRNA isoforms in human malignant breast tumors
by: S. V. Kropyvko, et al.
Published: (2018)
by: S. V. Kropyvko, et al.
Published: (2018)
Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: Chekhun, V.F., et al.
Published: (2015)
by: Chekhun, V.F., et al.
Published: (2015)
Human microbiota and effectiveness of cancer chemotherapy
by: Shvets, Yu.V., et al.
Published: (2023)
by: Shvets, Yu.V., et al.
Published: (2023)
Visualization of iron nanoparticles accumulation and distribution features in sensitive and resistant to antitumor drugs human breast cancer cells after different time intervals of cultivation with liposomal ferromagnetic
by: L. A. Nalieskina, et al.
Published: (2011)
by: L. A. Nalieskina, et al.
Published: (2011)
Expression of ITSN2 and TKS5 in different subtypes of breast cancer tumors
by: Kropyvko, S.V., et al.
Published: (2019)
by: Kropyvko, S.V., et al.
Published: (2019)
Hormonal-sensitive breast cancer: molecular-biological and clinical aspects of preoperative antitumor hormone therapy
by: O. V. Ponomareva
Published: (2018)
by: O. V. Ponomareva
Published: (2018)
Vascular endothelial growth factor exression in uterine cervical cancer: correlation with clinicopathologic characteristics and survival
by: Goncharuk, I.V., et al.
Published: (2009)
by: Goncharuk, I.V., et al.
Published: (2009)
Epigenetics in breast cancer
by: Atalay, C.
Published: (2013)
by: Atalay, C.
Published: (2013)
Epigenetics in breast cancer
by: C. Atalay
Published: (2013)
by: C. Atalay
Published: (2013)
Similar Items
-
The value of iodide symporter for prognosis of breast cancer of different molecular subtypes
by: Yu. Lukianova, et al.
Published: (2017) -
Fractal dimension of the breast cancer cells resistant and sensitive to doxorubicin activity
by: Medviediev, O., et al.
Published: (2016) -
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012) -
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016) -
Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line
by: Rusetskaya, N.V., et al.
Published: (2011)